People · Operator
Named in public records as an officer, director or promoter · active 2015–2015 · Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Cannapharmarx, Inc. | — | Other | Series B | $38.8M | $2.8M | 2015 |
ROBERT LIESS at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside ROBERT LIESS on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Gary Cohen | 1 | 6 |
| Wendy DiCicco | 1 | 4 |
| JAMES SMEEDING | 1 | 3 |
| Matthew Nicosia | 1 | 3 |
| CHRISTOPHER SCHNITTKER | 1 | 2 |
| GARY HERICK | 1 | 2 |
| GERRY CROCKER | 1 | 2 |
| ROBERT "BO" LIESS | 1 | 1 |
| STEVEN RULE | 1 | 1 |
| REDGIE T. GREEN | 1 | 1 |
| DAVID POHL | 1 | 1 |
| GERALD CROCKER | 1 | 1 |
| MATHEW SHERWOOD | 1 | 1 |
| ALEX GIAQUINTO | 1 | 1 |
| ELIE KHALIFE | 1 | 1 |
| DAVID J. CUTLER | 1 | 1 |
| James Samuelson | 1 | 1 |
| Dominick Colvin | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.